Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine

Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine

Bibliographic Details
Main Authors: Michael Ament, Kathleen Day, Virginia L. Stauffer, Vladimir Skljarevski, Mallikarjuna Rettiganti, Eric Pearlman, Sheena K. Aurora
Format: Article
Language:English
Published: BMC 2021-08-01
Series:The Journal of Headache and Pain
Online Access:https://doi.org/10.1186/s10194-021-01307-6
id doaj-5240f84726784d70ad35407c5199847a
record_format Article
spelling doaj-5240f84726784d70ad35407c5199847a2021-08-29T11:40:55ZengBMCThe Journal of Headache and Pain1129-23691129-23772021-08-012211210.1186/s10194-021-01307-6Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraineMichael Ament0Kathleen Day1Virginia L. Stauffer2Vladimir Skljarevski3Mallikarjuna Rettiganti4Eric Pearlman5Sheena K. Aurora6Ament Headache CenterEli Lilly and CompanyEli Lilly and CompanyEli Lilly and CompanyEli Lilly and CompanyEli Lilly and CompanyEli Lilly and Companyhttps://doi.org/10.1186/s10194-021-01307-6
collection DOAJ
language English
format Article
sources DOAJ
author Michael Ament
Kathleen Day
Virginia L. Stauffer
Vladimir Skljarevski
Mallikarjuna Rettiganti
Eric Pearlman
Sheena K. Aurora
spellingShingle Michael Ament
Kathleen Day
Virginia L. Stauffer
Vladimir Skljarevski
Mallikarjuna Rettiganti
Eric Pearlman
Sheena K. Aurora
Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
The Journal of Headache and Pain
author_facet Michael Ament
Kathleen Day
Virginia L. Stauffer
Vladimir Skljarevski
Mallikarjuna Rettiganti
Eric Pearlman
Sheena K. Aurora
author_sort Michael Ament
title Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
title_short Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
title_full Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
title_fullStr Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
title_full_unstemmed Correction to: Effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
title_sort correction to: effect of galcanezumab on severity and symptoms of migraine in phase 3 trials in patients with episodic or chronic migraine
publisher BMC
series The Journal of Headache and Pain
issn 1129-2369
1129-2377
publishDate 2021-08-01
url https://doi.org/10.1186/s10194-021-01307-6
work_keys_str_mv AT michaelament correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
AT kathleenday correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
AT virginialstauffer correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
AT vladimirskljarevski correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
AT mallikarjunarettiganti correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
AT ericpearlman correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
AT sheenakaurora correctiontoeffectofgalcanezumabonseverityandsymptomsofmigraineinphase3trialsinpatientswithepisodicorchronicmigraine
_version_ 1721186443553931264

Similar Items